EDITORIAL
Accepted on 21 Jul 2025
Editorial: Regulatory Science and Meta Science as Components of Regulation of Medical Products and Practices
doi 10.3389/fmed.2025.1664402
- 228 views
- Frontiers in Medicine
- Regulatory Science
- Research Topics
- Regulatory Science and Meta Science as Components of Regulation of Medical Products and Practices
Regulatory Science and Meta Science as Components of Regulation of Medical Products and Practices
3,840
Total downloads
19k
Total views and downloads
Articles
PERSPECTIVE
Published on 01 Apr 2025
The Innovative Health Initiative public–private partnership: a catalyst for big data-driven health research and innovation
doi 10.3389/fmed.2025.1554948
- 1,366 views
HYPOTHESIS AND THEORY
Published on 24 Jan 2025
A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapies
doi 10.3389/fmed.2025.1493832
- 1,280 views
PERSPECTIVE
Published on 07 Jan 2025
Gaps in the ethical governance of pharmaceutical clinical trials in Europe
doi 10.3389/fmed.2024.1507021
- 1,243 views
POLICY AND PRACTICE REVIEWS
Published on 16 Dec 2024
Biobanks and data interoperability in Latin America: engendering high-quality evidence for the global research ecosystem
doi 10.3389/fmed.2024.1481891
- 1,382 views
ORIGINAL RESEARCH
Published on 29 Aug 2024
Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency
doi 10.3389/fmed.2024.1437970
- 1,010 views
- 3 citations
ORIGINAL RESEARCH
Published on 31 Jul 2024
More than red tape: exploring complexity in medical device regulatory affairs
doi 10.3389/fmed.2024.1415319
- 3,928 views
- 4 citations
OPINION
Published on 03 Jul 2024
Enhancing the quality and efficiency of regulatory science literature reviews through innovation and collaboration with library and information science experts
doi 10.3389/fmed.2024.1434427
- 1,335 views
- 3 citations
ORIGINAL RESEARCH
Published on 05 Apr 2024
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation
doi 10.3389/fmed.2024.1362253
- 3,276 views
- 1 citation
